Search
Close this search box.
Search
[custom_company_search_form]
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)

Stock Piper AI Index

Subscribe
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)
Hang Seng
17,369.09
(0.75%)
Dow Jones
41,393.78
(0.72%)
Nikkei 225
36,581.76
(-0.68%)
FTSE 100
8,273.09
(0.39%)
USD/AUD
0.6611
(-0.36%)
Bitcoin
54,860.55
(0.68%)
Oil
69.24
(0.39%)
Gold
2,606.20
(0.99%)
Lithium
36.58
(-3.5%)
Iron Ore
92.9
(-1.96%)

Neuren Pharmaceuticals Ltd

NEU

ASX

Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical firm dedicated to advancing therapies for brain injury, neurodevelopmental, and neurodegenerative disorders. At the forefront of their research are two pivotal drug products: NNZ-2566 and NNZ-2591. Operating across New Zealand, Australia, and the USA, NEU is strategically positioned to drive forward its mission of developing effective treatments that address critical neurological conditions on a global scale.

Latest Posts

Line Chart with Gradient
Price
$14.19
0.65 (4.8%)
At Close 20/09 (AEST)
Related Companies
DORSAVI LTD
$DVL
ARGENT BIOPHARMA LIMITED
$RGT
BPH GLOBAL LTD
$BP8DD
LTR PHARMA LIMITED
$LTP
RECCE PHARMACEUTICALS LTD
$RCE

Latest Posts

NEU

$NEU

Neuren (ASX: $NEU) announces positive Phase 2 trial results in Angelman syndrome

NNZ-2591 shows statistically significant and clinically meaningful improvements in children with Angelman syndrome

NEU

$NEU

Neuren Pharmaceuticals (ASX: $NEU) requests trading halt for pending Phase 2 clinical trial announcement

Company requests halt for analysis of Phase 2 clinical trial in Pitt Hopkins syndrome

NEU

$NEU

Neuren (ASX: $NEU) reports A$8.0 million net cash from operating activities in Q1 2024

Guidance for net sales of US$370-420 million for DAYBUETM in 2024

NEU

$NEU

Neuren (ASX: $NEU) reports trofinetide new drug submission for Rett syndrome accepted for priority review

Health Canada grants priority review for trofinetide new drug submission by Neuren's global partner Acadia Pharmaceuticals

Related Companies
ONCOSIL MEDICAL LTD
$OSL
NYRADA INC.
$NYR
GENETIC SIGNATURES LIMITED
$GSS
CRYOSITE LIMITED
$CTE
CLARITY PHARMACEUTICALS LTD
$CU6

ASX News, First
& Fast.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

By clicking Subscribe, you agree to our Terms & Conditions

© 2024 Stock Piper. All rights reserved

© 2024 Stock Piper.
All rights reserved

Blog

Healthcare
Materials
Real Estate
Consumer Staples
Consumer Discretionary Brief
Utilities

Company

About us
Terms of use
Privacy Policy

Support

Request Form
Contact Support
FAQ
Glossary

Socials

Facebook
Twitter
LinkedIn
© 2024 Stock Piper. All rights reserved
Social Media Auto Publish Powered By : XYZScripts.com
Join FREE Newsletter

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions